IP Verse

Methods For Treating Bowel Diseases - EP2252148B1

PatentPatent Analysis

EP2252148

SALIX PHARMACEUTICALS
Application Number
EP09715020A
Filing Date
Feb 26, 2009
Status
Revoked
Oct 25, 2024
Grant Date
Mar 20, 2019
External Links
Slate, Register, Google Patents
Similar Patents facing opposition
EP3628319B1
EP2350096B1

Bibliography

The patent EP2252148B1 was granted to Salix Pharmaceuticals on Mar 20, 2019 following the initial filing on Feb 26, 2009 under the application number EP09715020A . The current legal status of the patent is Revoked.

AI Generated Summary New

Patent Family

Patent Family

Patent Oppositions (3)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

KRAUS & LEDERER PARTGMBBDec 19, 2019ADMISSIBLE
TEVA PHARMACEUTICALSDec 19, 2019ADMISSIBLE
SANDOZDec 18, 2019ADMISSIBLE

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents